Article PDF
Avoid common mistakes on your manuscript.
References
Stanley A, Plotkin WO, Offit PA. Vaccines. 6th ed. New York: Elsevier, 2013. 1464–1480
Bahri F, Letaief A, Ernez M, Elouni J, Chekir T, Ben Ammou S, Jemni L. Neurological complications in adults following rabies vaccine prepared from animal brains. Presse Med, 1996, 25: 491–493
Seeff LB, Beebe GW, Hoofnagle JH, Norman JE, Buskell-Bales Z, Waggoner JG, Kaplowitz N, Koff RS, Petrini JL Jr, Schiff ER, et al. A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. N Engl J Med, 1987, 316: 965–970
Offit PA. The Cutter Incident: How America’s First Polio Vaccine Led to the Growing Vaccine Crisis. New Haven: Yale University Press, 2005
Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports/Centers for Disease Control. 1997, 46: 1–25
Miller D, Wadsworth J, Diamond J, Ross E. Pertussis vaccine and whooping cough as risk factors in acute neurological illness and death in young children. Dev Biol Stand, 1985, 61: 389–394
Peltola H, Heinonen OP. Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins. Lancet, 1986, 1: 939–942
Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF, Eddins DL, Bryan JA. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976–1977. Am J Epidemiol, 1979, 110: 105–123
Kelso JM, Jones RT, Yunginger JW. Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin. J Alergy Clin Immunol, 1993, 91: 867–872
Rotavirus vaccines: WHO position paper-January 2013. Wkly Epidemiol Rec, 2013, 88: 49–64
Gangarosa EJ, Galazka AM, Wolfe CR, Phillips LM, Gangarosa RE, Miller E, Chen RT. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet, 1998, 351: 356–361
Baker JP. The pertussis vaccine controversy in Great Britain, 1974–1986. Vaccine, 2003, 21: 4003–4010
Sabra A, Bellanti JA, Colón AR. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet, 1998, 351: 637–641
Health Protection Agency. Annual COVER report: 2005/06 Summary of trends in vaccination coverage in the UK. Available: http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1194947367316
Jansen VA, Stollenwerk N, Jensen HJ, Ramsay ME, Edmunds WJ, Rhodes CJ. Measles outbreaks in a population with declining vaccine uptake. Science, 2003, 301: 804
Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Melbye M. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med, 2002, 347: 1477–1482
Taylor B, Miller E, Farrington CP, Petropoulos MC, Favot-Mayaud I, Li J, Waight PA. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet, 1999, 353: 2026–2029
Cui FQ. Epidemiology of seroprevalence of hepatitis B in Chinese population-the hepatitis B vaccine immunization decreased the hepatitis B virus infection rate (in Chinese). Zhong Guo Yi Miao He Mian Yi, 2010, 16: 341–353
Mikaeloff Y, Caridade G, Rossier M, Suissa S, Tardieu M. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med, 2001, 344: 327–332
Confavreux C, Suissa S, Saddier P, Bourdès V, Vukusic S; Vaccines in Multiple Sclerosis Study Group. Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. N Engl J Med, 2001, 344: 319–326
Wang FZ, Cui FQ, Liu DW. Analysis on the adverse events following immunization of 10 infants death after hepatitis B vaccination (in Chinese). Zhong Guo Yi Miao He Mian Yi, 2009, 15: 52–57
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at link.springer.com
Biographical Sketch
Xia NingShao is Director of NIDVD, supervisor of State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, President of the School of Public Health of Xiamen University, doctoral supervisor, distinguished Minjiang Scholar and member of the “Ten Thousand Talent Plan” launched by the Organization Department of the Central Committee of the CPC. In addition, he holds a concurrent post as a part-time member of the 4th CSRC Growth Enterprise Board Public Offering Review Committee, president of “Infectious Disease Diagnostic Reagent Industrial Technology Innovation Strategic Alliance”, a member of the major national science and technology special “Prevention and Treatment of AIDS and Virus Hepatitis” program (principle expert team) and head of the Hepatitis Team, member of the Medical Biotechnology Subject Matter Panel of Experts of National High Technology Research and Development Program and member of the Reviewing Expertise Group of the Department of Health Sciences of the National Natural Science Foundation. He mainly engages in biomedical research, and has successively committed himself to many national major/key subjects (e.g. National High Technology Research and Development Program of China), managed and developed the world’s first hepatitis E vaccine, developed diagnostic products for AIDS, influenza, hand foot and mouth disease and hepatitis, won the second prize of the National Invention Awards, second prize of the National Science and Technology Progress Awards and Chinese Patent Gold Medal, was awarded 22 patents and 37 new drug/machinery certificates (one type I new drug, five EU certifications and one Taiwan certification), and has published more than 90 papers in The Lancet, Proc Natl Acad Sci USA and other SCI publications.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Wu, T., Zhang, J. & Xia, N. Rationally respond to post-vaccination adverse events. Sci. China Life Sci. 57, 557–560 (2014). https://doi.org/10.1007/s11427-014-4623-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-014-4623-4